Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression
Ran Zhang,
No information about this author
Yuyan Tang,
No information about this author
Xiangru Feng
No information about this author
et al.
Gut Microbes,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 28, 2025
IgA
nephropathy
(IgAN)
is
related
to
the
balance
of
gut
microbiota.
However,
it
unclear
whether
changes
in
microbiota
can
cause
IgAN
or
attenuate
its
progression.
This
study
employed
and
human
microbiota-associated
(HMA)-IgAN
models
investigate
impact
on
alteration
mechanisms
by
which
might
trigger
IgAN.
Furthermore,
this
examined
effects
chitooligosaccharides
(COS)
COS
formulation
(COSF)
with
microbiota-targeting
function
enhancing
intestinal
barrier
renal
functions.
These
results
revealed
that
led
a
reduction
α-diversity
structural
alterations
microbiota,
characterized
an
increase
Shigella
sonnei,
Streptococcus
danieliae,
Desulfovibrio
fairfieldensis,
decrease
Bifidobacterium
pseudolongum
Clostridium
leptum.
There
was
also
imbalance
B-cell
immunity
level
tight
junction
proteins
(ZO-1
Occludin).
Intestinal
mucosal
immune-related
(Clostridium
leptum,
unclassified
Lachnospiraceae
NK4Al36
group,
Clostridia
vadinBB60
Oscillospiraceae,
Roseburia)
were
enriched
through
targeted
modulation
COS/COSF,
ZO-1
expression
reducing
APRIL/BAFF
overexpression,
thereby
damage
In
conclusion,
clarified
kidney-gut
crosstalk
between
IgAN,
providing
scientific
evidence
for
developing
microbiota-targeted
food
interventions
improve
outcomes.
Language: Английский
The Influence and Mechanisms of Natural Plant Polysaccharides on Intestinal Microbiota-Mediated Metabolic Disorders
Yong Chen,
No information about this author
Hui Li,
No information about this author
Furao Lai
No information about this author
et al.
Foods,
Journal Year:
2024,
Volume and Issue:
13(23), P. 3882 - 3882
Published: Nov. 30, 2024
Natural
plant
polysaccharides
are
renowned
for
their
broad
spectrum
of
biological
activities,
making
them
invaluable
in
both
the
pharmaceutical
and
food
industries.
Their
safety,
characterized
by
low
toxicity
minimal
side
effects,
coupled
with
potential
therapeutic
properties,
positions
as
crucial
elements
health-related
applications.
The
functional
effectiveness
these
is
deeply
connected
to
structural
attributes,
including
molecular
weight,
monosaccharide
components,
types
glycosidic
bonds.
These
influence
how
interact
gut
microbiota,
potentially
alleviating
various
metabolic
inflammatory
disorders
such
bowel
disease,
diabetes,
liver-associated
pathologies,
obesity,
kidney
diseases.
operate
through
a
range
mechanisms.
They
enhance
formation
short-chain
fatty
acids,
which
pivotal
keeping
intestinal
health
balance.
Additionally,
they
strengthen
mucosal
barrier,
deterring
ingress
pathogens
toxins
into
host
system.
By
modulating
immune
responses
within
gut,
help
managing
immune-mediated
disorders,
role
activating
specific
cellular
signaling
pathways
further
underscores
potential.
review
delves
intricate
structure-activity
relationships
natural
interactions
flora.
understanding
relationships,
scientific
community
can
develop
targeted
strategies
use
therapeutics,
leading
innovative
treatments
Furthermore,
insights
gained
drive
advancement
research
polysaccharide
applications,
providing
direction
novel
dietary
supplements
foods
designed
support
overall
well-being.
Language: Английский